Identification of prognostic factors in patients with brain metastases: a review of 1292 patients.
about
Chance mechanisms affecting the burden of metastases.Brain metastasis in human epidermal growth factor receptor 2-positive breast cancer: from biology to treatmentCombining Whole-Brain Radiotherapy with Gefitinib/Erlotinib for Brain Metastases from Non-Small-Cell Lung Cancer: A Meta-AnalysisThe use of dynamic nuclear polarization (13)C-pyruvate MRS in cancerPatients with single brain metastasis from non-small cell lung cancer equally benefit from stereotactic radiosurgery and surgery: a systematic reviewCharacteristics and treatments of large cystic brain metastasis: radiosurgery and stereotactic aspirationMotexafin gadolinium in the treatment of brain metastasesIs upfront stereotactic radiosurgery a rational treatment option for very elderly patients with brain metastases? A retrospective analysis of 106 consecutive patients age 80 years and olderImproved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma.Primary malignant melanoma in the pineal region treated without chemotherapyBrain metastasis: clinical characteristics, pathological findings and molecular subtyping for therapeutic implications.Resection versus radiosurgery for patients with brain metastases.Results of the whole-brain radiotherapy for patients with brain metastases from lung cancer: the RTOG RPA intra-classes analysis.Prognostic factors affecting the outcome of brain metastases from breast cancer.EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force.Gemcitabine twice weekly as a radiosensitiser for the treatment of brain metastases in patients with carcinoma: a phase I studyPhase II study of temozolomide and concomitant whole-brain radiotherapy in patients with brain metastases from solid tumors.Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study.Intra-operative MRI (iop-MR) for brain tumour surgery.Intracranial dural metastases.Prognostic indices for brain metastases--usefulness and challengesPresentation and outcome in cancer patients with extensive spread to the brain.DEGRO Practical Guidelines for palliative radiotherapy of breast cancer patients: brain metastases and leptomeningeal carcinomatosis.Whole brain radiotherapy with a conformational external beam radiation boost for lung cancer patients with 1-3 brain metastasis: a multi institutional studyCritical appraisal of the role of gefitinib in the management of locally advanced or metastatic non-small cell lung cancerEvaluation of results of linac-based radiosurgery for brain metastases from primary lung cancer.Use of dexamethasone in patients with high-grade glioma: a clinical practice guidelineValidation of the new Graded Prognostic Assessment scale for brain metastases: a multicenter prospective study.Brain metastases from breast cancer: proposition of new prognostic score including molecular subtypes and treatment.Brain metastases from colorectal carcinoma: a description of 60 cases in a single Chinese cancer center.Brain metastases from breast cancer: prognostic significance of HER-2 overexpression, effect of trastuzumab and cause of deathPredicting compliance and survival in palliative whole-brain radiotherapy for brain metastases.Brain metastases from hepatocellular carcinoma: clinical features and prognostic factorsAdjuvant treatment of brain metastases.Caveolin-1 upregulation mediates suppression of primary breast tumor growth and brain metastases by stat3 inhibition.Prospective evaluation of quality of life effects in patients undergoing palliative radiotherapy for brain metastasesBrain metastases in gastrointestinal cancers: is there a role for surgery?Efficacy and toxicity of whole brain radiotherapy in patients with multiple cerebral metastases from malignant melanomaBreast cancer metastasis to the central nervous systemEGFR mutations are associated with favorable intracranial response and progression-free survival following brain irradiation in non-small cell lung cancer patients with brain metastases
P2860
Q24811341-A8CA96AE-4846-43A5-A140-D2DE773372F6Q26751008-5684154A-4C6D-4C99-A482-8F822D6C3D3AQ26752378-EC80F470-70F7-4B2A-AADF-2288902A4FAEQ26778444-1BE97C15-D0C6-40F9-A9CD-2DC844238EAEQ26865729-D37D24B8-4B79-4568-BB4C-9769D376673CQ28082116-E9DA7ADA-E430-444C-9457-B008E4761E67Q28285963-4BD7E726-8A29-492D-B426-56A5E570C04AQ28396583-ED5DE7AF-8116-48AE-A8A2-58F2981D86F3Q30448863-E0545B82-2451-495E-A118-C37770B126F2Q30460114-D7EA8EC1-C0BD-43F9-A9EE-CAEBF0795558Q31010216-FC8462F6-392F-40C2-90FF-6ECD17AC19A6Q31097790-AFABD445-2326-401F-BBFF-EED5781B37A3Q33222212-538FCB52-A774-4C01-951B-09730E7F317DQ33238114-0560E7FC-DD58-487C-B65E-CF4200E8E239Q33249813-EA9593D4-0043-4303-804E-9B2764A8A24CQ33365043-C4500FA0-E374-4E56-935D-7F7F2D27B3D9Q33375710-6A54B7A4-CF25-4EF3-A006-F1253FCE5BFEQ33386298-EA6E7573-B7EF-45D8-82E9-12A56F26715EQ33411344-69324636-4DCD-424D-A798-444C65C5ED2CQ33412217-6E70BE1B-BFFA-4638-AACE-1C51AD87C9CAQ33414874-AD72E195-1260-43AA-9593-38CADDFA08F9Q33517956-4BE82448-B2D5-4B48-A27C-D086FD93DE75Q33529158-99D9B59A-B90B-4622-80C5-37DFD253FF86Q33532301-6DB532A8-CBC4-4521-8189-E82470DE2732Q33710152-0FCE1DFB-690E-4950-B681-B37812F43CC6Q33751488-B7010CC3-3022-47E6-87CE-36FE596931A4Q33763941-8BEAC8E6-9720-448E-9FF8-7C01D4AA53A7Q33834894-522CF539-CD6B-46D4-92D1-343CD23CEA20Q33953465-98F663ED-937D-44F9-8DED-DE319E95F064Q34018126-835BA5B4-95D6-4E9F-A1E0-ED69C660C783Q34022312-19C8E84B-7C70-4646-8E0C-B34D39B6FF5CQ34134011-D9EA003F-276A-4FD6-B5F1-272C6F80DE49Q34146919-9E65D99E-B147-4B5A-8B98-27F6296EE0F2Q34210478-4DA160C6-384A-4DFD-8F1E-7681EC453274Q34222800-38145A6A-D39B-4A55-ADC1-04987B84ABDAQ34332364-32EC05FF-E72E-49B5-B564-38526FFBD899Q34358783-722A3DE4-060D-44EF-B237-DC5D09F4B702Q34362809-B1E28A5E-9664-48FE-8357-BB739BFED3CEQ34455205-E0FA3C63-B5A9-4596-A44D-0328E5F6C913Q34461771-1EF530E6-ADCD-40EE-930E-44A75936F812
P2860
Identification of prognostic factors in patients with brain metastases: a review of 1292 patients.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Identification of prognostic f ...... es: a review of 1292 patients.
@ast
Identification of prognostic f ...... es: a review of 1292 patients.
@en
type
label
Identification of prognostic f ...... es: a review of 1292 patients.
@ast
Identification of prognostic f ...... es: a review of 1292 patients.
@en
prefLabel
Identification of prognostic f ...... es: a review of 1292 patients.
@ast
Identification of prognostic f ...... es: a review of 1292 patients.
@en
P2093
P1476
Identification of prognostic f ...... es: a review of 1292 patients.
@en
P2093
Eijkenboom WM
Hanssens PE
Lagerwaard FJ
Levendag PC
Schmitz PI
P304
P356
10.1016/S0360-3016(98)00442-8
P407
P577
1999-03-01T00:00:00Z